Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

India's drug regulator has granted emergency use permission to single-dose Sputnik Light Covid vaccine in the country, Union Health Minister Mansukh Mandaviya said on Sunday.
The minister tweeted that Sputnik Light is the 9th Covid-19 vaccine in the country and it will further strengthen the nation's collective fight against the pandemic
Sputnik-Light is the single dose version of Russia's Covid-19 vaccine Sputnik V. Both vaccines are distributed in India by Dr Reddy's Laboratories. 
Also watch: Covid vaccine, precaution doses can be taken only 3 months after recovery: Govt
The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina and that the interim data of efficacy trial from Russia has shown 65.4 per cent efficacy, 21 days after immunisation.

Covid-19 | Sputnik Light vaccine granted emergency use authorisation in India

India's drug regulator has granted emergencyuse permission to single-dose Sputnik Light Covid vaccine in the country

Sputnik Light vaccine granted emergency use authorisation in India
Sputnik Light is a single dose Russian vaccine
Health Minister: Sputnik Light is the 9th vaccine in India
Sputnik V and Light distributed in India by Dr Reddy's

Sputnik-Light&nbsp;is the single dose version of Russia's Covid-19 vaccine Sputnik V.&nbsp;Both vaccines are distributed in India by Dr Reddy's&nbsp;Laboratories.&nbsp;

India's drug regulator has granted emergency use permission to single-dose Sputnik Light Covid vaccine in the country, Union Health Minister Mansukh Mandaviya said on Sunday.
The minister tweeted that Sputnik Light is the 9th Covid-19 vaccine in the country and it will further strengthen the nation's collective fight against the pandemic
Sputnik-Light&nbsp;is the single dose version of Russia's Covid-19 vaccine Sputnik V.&nbsp;Both vaccines are distributed in India by Dr Reddy's&nbsp;Laboratories.&nbsp;
Also watch:&nbsp;<a href="https://www.editorji.com/coronavirus/covid-vaccine-precaution-doses-can-be-taken-only-3-months-after-recovery-govt-1642827608095">Covid vaccine, precaution doses can be taken only 3 months after recovery: Govt</a>
The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina and that the interim data of efficacy trial from Russia has shown 65.4 per cent efficacy, 21 days after immunisation.

Dr. Reddy's Laboratories has been denied permission by India's top regulatory body to conduct the Phase-3 trials for Sputnik Light vaccine in India,&nbsp;according to reports.&nbsp;The expert committee of the Central Drugs Standard Control Organisation refused to allow the Hyderabad-based pharmaceutical company to conduct the third phase trials for the Russian-made vaccine because it did not find the "scientific rationale" behind the same.
Sputnik Light is a one-shot version of Sputnik V that the government was earlier looking at for a speedy launch in India.&nbsp;
Dr. Reddy's Laboratories had partnered with the Russian Direct Investment Fund last year in September to&nbsp;distribute up to 100 million doses of Sputnik V&nbsp;in India. The vaccine was approved for emergency use in the country in April this year.

Dr Reddy's denied permission to hold phase-3 trial for Russia's Sputnik Light

Dr. Reddy's Laboratories has been denied permission by India's top regulatory body to conduct the Phase-3 trials for Sputnik Light vaccine in India,&nbsp;according to reports.&nbsp;The expert committee of the Central Drugs Standard Control Organisation refused to allow the Hyderabad-based pharmaceutical company to conduct the third phase trials for the Russian-made vaccine because it did not find the "scientific rationale" behind the same.
Sputnik Light is a one-shot version of Sputnik V that the government was earlier looking at for a speedy launch in India.&nbsp;
Dr. Reddy's Laboratories had partnered with the Russian Direct Investment Fund last year in September to&nbsp;distribute up to 100 million doses of Sputnik V&nbsp;in India. The vaccine was approved for emergency use in the country in April this year.

Sputnik Light is a one-shot version of Sputnik V that the government was earlier looking at for a speedy launch in India.&nbsp;

While Russia's Sputnik V vaccine is already available in India, Dr Reddys&nbsp;Laboratories CEO&nbsp;Deepak&nbsp;Sapra&nbsp;has said that his company is now trying to seek regulatory approval for the single-dose Sputnik V Light vaccine. The Hyderabad-based pharma&nbsp;giant has also partnered with the Russian Direct Investment Fund (RDIF) to bring the 2 dose vaccine to India. Sapra&nbsp;who confirmed that the Clinical trials of the single-dose vaccine are being conducted in Russia&nbsp;added&nbsp;that Sputnik Light's single shot will be able to give 80% efficacy. Hoping that the vaccine is approved for use in India, he further said that Sputnik Light will be a shot in the arm for the country's vaccination program. Moreover, the CEO&nbsp;of the company also assured that Sputnik V which is currently being administered in a few private hospitals of India will&nbsp;be more affordable as the production starts in India.&nbsp;

Working with regulators to bring Sputnik Light to India: Dr. Reddy's Laboratories

Dr Reddy's&nbsp;CEO:&nbsp;&nbsp;seeking regulatory approval for Sputnik Light
Sapra&nbsp;said single-dose Sputnik Light vaccine gives 80% efficacy
Sapra: Sputnik Light a shot in the arm for India's vaccination program

Dr Reddy's&nbsp;Laboratories CEO&nbsp;Deepak&nbsp;Sapra&nbsp;has said that his company is trying to seek regulatory approval for the single-dose Sputnik V Light vaccine in India. &nbsp;Sapra&nbsp;who confirmed that the Clinical trials of the single-dose vaccine are being conducted in Russia&nbsp;added&nbsp;that Sputnik Light's single shot will be able to give 80% efficacy. He further said that Sputnik Light will be a shot in the arm for the country's vaccination program.&nbsp;NITI Aayog's&nbsp;Dr VK Paul said at a press conference earlier this month that they are investigating&nbsp;Russian Direct Investment Fund's (RDIF) claim that the first dose of Sputnik Light is enough.

sputnik light vaccine

Categories